热门资讯> 正文
Lunai Bioworks将实施10:1反向股票分割
2025-09-25 04:59
- Lunai Bioworks (NASDAQ:RENB) announced on Wednesday that the company's Board of Directors has approved a 10:1 reverse stock split of its issued and outstanding common stock, to be effective on September 30, 2025.
- The company's common stock will trade on Nasdaq under the symbol "LNAI" following the reverse stock split, with a new CUSIP number of 29350E 203.
- The company expects its common stock to open for trading on a post-split basis on Nasdaq as of the commencement of trading on September 30, 2025.
- The reverse stock split is expected to reduce the number of shares of the company's common stock outstanding from approximately 231,780,434 shares to approximately 23,178,096 shares subject to some variability as a result of the fractional upward adjustments.
- RENB -24.68% after hours to $0.13.
More on Lunai Bioworks Inc.
- Financial information for Lunai Bioworks Inc.
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。